ENTITY

Dongwha Pharm (000020 KS)

5
Analysis
Health CareSouth Korea
Dongwha Pharm Co., Ltd. produces over-the-counter drugs, such as antipyretics, analgesics, and antibiotics for cardiovascular, dermatological, and alimentary ailments. Dongwha also manufactures insecticides and nutritional products.
more
01 Dec 2024 07:30

APAC Healthcare Weekly (Dec 1)- Celltrion, Eoflow, Lunit, Hansoh, Kelun Biotech, Eisai, Dr. Reddy’s

​Celltrion, Hansoh Pharma, and other pharmaceutical companies are making significant strides in expanding their business and launching new drugs in...

Logo
733 Views
Share
02 Feb 2018 21:52

Enzychem Lifesciences New IPO Book Summary

Enzychem Lifesciences Corp (183490 KS) submitted the revised version of IPO book on Jan 22. Here is the link of this new IPO...

Logo
290 Views
Share
21 Jan 2018 04:15

Enzychem Lifesciences IPO Rescheduling Summary

Enzychem Lifesciences Corp (183490 KS), which is Korea's first major and serious IPO this year, announced (around 6 PM Friday Jan 19) that it had...

Logo
275 Views
Share
07 Jul 2016 00:13

SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing

SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...

Logo
3.5k Views
Share
No more insights
x